VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

9480	Companies
185523	Keywords
117911	Articles
99370	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 10/29/2024 at 17:40, 1 year 1 month ago

VALBIOTIS publishes its interim financial statements
Valbiotis publishes interim financial statements for H1 2024 showing a cash position of €18.5M and confirming its commercial roadmap. Key events review the successful launch of Valbiotis@PRO Cholesterol

Cash Position Valbiotis Product Launch Interim Financial Statements Commercial Roadmap
BRIEF

published on 10/17/2024 at 17:45, 1 year 1 month ago

Valbiotis: Ordinary General Meeting of November 5, 2024

Shareholders Liquidity Contract Valbiotis General Assembly Food Supplements
BRIEF

published on 10/15/2024 at 17:45, 1 year 1 month ago

Valbiotis celebrates the success of the INSIGHT study on TOTUM•854

Valbiotis Clinical Study INSIGHT Hypertension TOTUM•854
PRESS RELEASE

published on 10/15/2024 at 17:40, 1 year 1 month ago

Valbiotis announces the major success of the INSIGHT clinical study on TOTUM•854
Valbiotis announces major success of INSIGHT clinical study on TOTUM 854, demonstrating efficacy in reducing systolic blood pressure in individuals with untreated mild hypertension. Validation of innovative plant-based active ingredients

Valbiotis Plant-based INSIGHT Clinical Study TOTUM 854 Systolic Blood Pressure
BRIEF

published on 10/09/2024 at 17:50, 1 year 1 month ago

Valbiotis: Information on voting rights and shares, September 2024

Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossings
BRIEF

published on 10/09/2024 at 17:50, 1 year 1 month ago

Update on Valbiotis voting rights for September 2024

Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF

published on 09/12/2024 at 17:50, 1 year 2 months ago

VALBIOTIS: Monthly information on voting rights and shares in August 2024

Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF

published on 09/12/2024 at 17:50, 1 year 2 months ago

Valbiotis: Monthly Information on Voting Rights and Shares - August 2024

Voting Rights Euronext Actions Transparency Valbiotis
BRIEF

published on 09/05/2024 at 17:45, 1 year 3 months ago

Valbiotis to Present at 2024 EASD Congress

Valbiotis TOTUM•63 Prediabetes Type 2 Diabetes EASD 2024
PRESS RELEASE

published on 09/05/2024 at 17:40, 1 year 3 months ago

VALBIOTIS : Oral presentation at the 2024 EASD congress
Valbiotis selected to present clinical results from TOTUM 63 Phase II/III clinical study in prediabetes and type 2 diabetes at 2024 EASD congress. Innovative non-drug solution against type 2 diabetes epidemic

Valbiotis Prediabetes TOTUM 63 Clinical Results Type 2 Diabetes

Accesswire

Published on 12/05/2025 at 18:20, 14 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 34 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 19 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 34 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 34 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:26, 7 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 18 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 42 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 47 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 33 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 15 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 23 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 9 hours 49 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 1 day ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 1 day ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE